ArticleCancer cell international2026

NPTXR as a novel therapeutic target: efficacy of antibody-drug conjugates in preclinical tumor models.

Mykola Lyndin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.